Skip to content

Sepsis Prediction by Monocyte Distribution Width and Procalcitonin

Comparison of the Diagnostic Accuracy of Monocyte Distribution Width and Procalcitonin on Sepsis in the Emergency Department

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04322942
Enrollment
600
Registered
2020-03-26
Start date
2019-04-16
Completion date
2020-09-30
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnoses Disease, Sepsis

Keywords

sepsis, procalcitonin, MDW

Brief summary

The mortality rate of sepsis remains as high as 30 to 40%. Early diagnosis and treatment of patients with sepsis reduce mortality significantly. The most commonly used biomarkers in clinical practice are C-reactive protein (CRP) and procalcitonin (PCT). In terms of exploring new diagnostic tools of sepsis, monocyte distribution width (MDW) was first reported in 2017. It was reported as part of the white blood cell (WBC) differential count. MDW greater than 20 and abnormal WBC count together were reported to provide a satisfactory accuracy. The area under curve (AUC) in predicting sepsis-2 is 0.852. It was proposed as a novel diagnostic tool of sepsis in the emergency setting. Nonetheless, the performance of MDW compared with the conventional biomarkers remained unknown. The aim of this study was to compare the diagnostic accuracy of MDW and PCT on sepsis in the emergency department.

Interventions

Monocyte Distribution Width as part of the CBC result.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subject Inclusion Criteria * Adult ≥20 years) subjects presenting to the ED with the chief complaints of fever, altered consciousness, hypotension, and dyspnea. CBC with differential testing performed, at presentation as part of their standard medical care. * Subjects who have signed Informed Consent. Subject

Exclusion criteria

* Previously enrolled in this study (i.e. subjects may not be enrolled more than once in this study) * Subjects discharged from the ED \<72 hours * Pregnant women * Subjects not able to understand or sign Informed Consent

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity of predicting sepsis and sepsis-3 patientswithin 2 hours after patient arrived ED.MDW, PCT, and other laboratory tests were all obtained at the same time with 2 hours after the patient was admitted to the emergency department (ED). Sensitivity and specificity of different cutoff value were calculated. Best cutoff value will be decided by the perfomance.

Countries

Taiwan

Contacts

Primary ContactChih-huang Li, MD
chhli2002@gmail.com0975360718

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026